Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New System for Eye Surgery Targets Emerging Markets

By HospiMedica International staff writers
Posted on 23 Feb 2009
A new system for the surgical treatment of cataracts of has been specifically tailored to meet a continuing high level of demand in emerging markets, particularly in Asia.

The Visalis 100 system enables the surgical removal of the natural, diseased lens from the eye during phacoemulsification cataract surgery. More...
The system is designed for maximum patient safety and features a completely closed design. There is no internal tubing requiring cleaning, thus eliminating the risk of cross-contamination, while increasing the predictability of outcomes. The system's adaptive power control (APC) provides additional safety by delivering surgeons the minimal power necessary during the procedure, and a surge security system that stabilizes the anterior chamber. The stroke is measured and stabilized by a microprocessor, and an intuitive graphical user interface (GUI) with large display, touch-driven control, and voice confirmation allows easy adjustment of the system.

Phacoemulsification is performed with a piezoelectric handpiece controlled by either a panel switch or linear control via a system footswitch. Vitrectomy adjustable cutting speed from 60 to 700 cuts per minute, with an available single mode cut. Due to inherent reliability and stability, the systems servicing and maintenance requirements are very low. The compact, lightweight design and small footprint require very little space, which is convenient for restricted space in the operating room, or when the system needs to be transported to multiple locations. The Visalis 100 system is a product of Carl Zeiss Meditec (Oberkochen, Germany).

"The response from doctors was outstanding. The resulting demand clearly confirms our strategy to continue focusing our developments on the requirements of our customers in the various regions of the world,” said Dr. Michael Kaschke, President and CEO of Carl Zeiss Meditec.

Related Links:

Carl Zeiss Meditec




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.